期刊文献+

舒洛地特治疗2型糖尿病肾病患者不稳定性心绞痛的疗效观察 被引量:1

下载PDF
导出
摘要 目的观察舒洛地特治疗2型糖尿病肾病患者心绞痛的疗效。方法连续入选106例住院患者,随机分为治疗和对照组,治疗组在对照组常规治疗方案加用舒洛地特,4周后观察疗效及凝血相关指标。结果治疗4周后,治疗组临床有效率及心电图改善情况均优于对照;治疗组fib低于对照组,APTT、PT、TT均较对照组延长。结论舒洛地特联合常规治疗能更有效地改善2型糖尿病肾病患者高凝状态及心绞痛症状。
作者 魏文锋
出处 《心血管病防治知识(学术版)》 2018年第6期38-40,共3页 Prevention and Treatment of Cardiovascular Disease
  • 相关文献

参考文献4

二级参考文献28

  • 1Weiss R, Niecestro R, Raz I. The role of sulodexide in the treatment of diabetic nephropathy [J]. Drugs, 2007,67(18): 2 681-2 696.
  • 2Blouza S, Dakhli S, Abid H, et al. Efficacy of low-dose oral sulodexide in the management of diabetic nephrop- athy[J]. J Nephrol, 2010, 23(4):415-424.
  • 3Solini A, Carraro A, Barzon I, et al. Therapy with glycosaminoglycans lowers albumin excretion in non- insulin dependent diabetic patients with microalbumin- uria[J]. Diabetes Nutr Metab, 1994, 7:304-307.
  • 4Lewis EJ, Lewis JB, Greene T, et al. Sulodexide forkidney protection in type 2 diabetes patients with mi- croalbuminuria: A randomized controlled trial[J]. Am J Kidney Dis, 2011,58(5) :729-736.
  • 5Broekhuizen LN, Lemkes BA, Mooij HL, et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus [J]. Diabetologia, 2010, 53(12):2 646-2 655.
  • 6Ciszewicz M, Polubinska A, Antoniewicz A, et al. Su- lodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity[J]. Transl Res, 2009, 153(3): 118-123.
  • 7英俊歧,胡大一.循证心脏病学问答[M].北京:化学工业出版社,2005:151-152.
  • 8Mehta D,Curwin J,Gomes JA,et al.Sudden death in coronary artery disease:acute ischemia versus myocardial substrate[J].Circulation.,1997,96(9):3215-3123.
  • 9Théroux P,Fuster V.Acute coronary syndromes:unstable angina and non-Q-wave myocardial infarction[J].Circulation,1998,97(12):1195-1206.
  • 10李新柱.脉血康治疗不稳定性心绞痛的疗效观察[J].中国现代药物应用,2010,19(10):1780.

共引文献251

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部